We are live on
!
Find out more
SCP
Shorepoint Capital Partners Portfolio holdings
AUM
$503M
This Fund
S&P 500
This Quarter
Est. Return
+6.93%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$187M
AUM Growth
+$6.59M
(+3.7%)
Cap. Flow
-$4.83M
Cap. Flow
% of AUM
-2.58%
Top 10 Holdings %
Top 10 Hldgs %
32.6%
Holding
82
New
6
Increased
33
Reduced
34
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Ultra-Short Municipal Income ETF
JMST
|
+$3.06M |
| 2 |
American Tower
AMT
|
+$762K |
| 3 |
Merck
MRK
|
+$663K |
| 4 |
Sherwin-Williams
SHW
|
+$386K |
| 5 |
Bristol-Myers Squibb
BMY
|
+$379K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$2.95M |
| 2 |
Abbott
ABT
|
+$1.71M |
| 3 |
JPMorgan Chase
JPM
|
+$922K |
| 4 |
PNC Financial Services
PNC
|
+$868K |
| 5 |
Pfizer
PFE
|
+$740K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.6% |
| 2 | Technology | 13.02% |
| 3 | Financials | 11.46% |
| 4 | Industrials | 8.56% |
| 5 | Consumer Staples | 6.64% |
Similar funds
VBFG
JWM
FNC
OHWA
ODG
GP
SCA
SFPM
Shorepoint Capital Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Shorepoint Capital Partners held 82 positions worth $187M, up 3.7% from $180M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Shorepoint Capital Partners's Q1 2021 filing shows 6 new, 33 increased, 34 reduced and 5 closed positions. Its largest new stake was American Tower: 3,421 shares worth $818K. The largest sale was AbbVie, an estimated $2.95M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Technology and Financials.
- Shorepoint Capital Partners's largest Q1 2021 buy was American Tower: 3,421 shares worth $818K.
- Shorepoint Capital Partners added most to JPMorgan Ultra-Short Municipal Income ETF in Q1 2021, an estimated $3.06M increase.
- Shorepoint Capital Partners's biggest Q1 2021 reduction was AbbVie, cutting an estimated $2.95M.
- Shorepoint Capital Partners fully exited Pfizer in Q1 2021, selling an estimated $740K.
- Shorepoint Capital Partners's ten largest holdings make up 33% of its $187M portfolio in Q1 2021.
- Shorepoint Capital Partners opened 6 new positions and closed 5 in Q1 2021.
- Shorepoint Capital Partners's portfolio value rose 3.7% quarter-over-quarter to $187M.
Based on Shorepoint Capital Partners's 13F filing for Q1 2021, filed 10 May 2021.